In mouse CLP-sepsis, treatment with IKK inhibitor IKK 16, a 2-benzamido-pyrimidine, decreased the activity of the IKK complex (54), reduced IκBα phosphorylation, and inhibited nuclear translocation of NF-κB (55). The gene discussed is NFKB1; the disease is Sepsis.